David J.A. Jenkins et al. JACC 2018;71:

Slides:



Advertisements
Similar presentations
Supplemental Figure 1 A No. at risk T T T
Advertisements

Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.
CaD TrialObservational Study All participantsNo Personal Supplements a Non-users ofCalcium +CalciumVitamin D PlaceboCaDPlaceboCaDSupplementsVitamin DOnly.
WOSCOPS: West Of Scotland Coronary Prevention Study Purpose To determine whether pravastatin reduces combined incidence of nonfatal MI and death due to.
Enrollment and Outcomes Duckworth W, et al. N Engl J Med 2009;360:
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Causal Assessment of Serum Urate Levels in Cardiometabolic.
Fat or Low-fat? Anwar T. Merchant ScD, MPH, DMD Department of Epidemiology and Biostatistics.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.
Date of download: 6/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effects of Homocysteine-Lowering With Folic Acid.
Date of download: 6/18/2016 From: Treatment of Anemia in Patients With Heart Disease: A Systematic Review Ann Intern Med. 2013;159(11): doi: /
Date of download: 6/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Cardiorespiratory Fitness as a Quantitative Predictor.
Arch Intern Med. 2004;164(13): doi: /archinte Figure Legend:
Flow of Individuals Through the Vitamin E and Vitamin C Components of the Physicians’ Health Study II Howard D. Sesso et al. JAMA 2008;300:
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2004 American Medical Association. All rights reserved.
A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids.
First time a CETP inhibitor shows reduction of serious CV events
Risk of Heart Failure Among Postmenopausal WomenCLINICAL PERSPECTIVE
Ahmed Abuzaid, MD, Carly Fabrizio, DO, Kevin Felpel, MD, Haitham S
A Meta-Analysis of Randomized Controlled Trials and Prospective Cohort Studies of Eicosapentaenoic and Docosahexaenoic Long-Chain Omega-3 Fatty Acids.
Duration of Dual Antiplatelet Therapy in Patients with an Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention  Chirag Bavishi, MD, MPH,
David J.A. Jenkins et al. JACC 2018;71:
Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease  Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,
Effect of beta-blockers on perioperative outcomes in vascular and endovascular surgery: a systematic review and meta-analysis  S Hajibandeh, S Hajibandeh,
Baseline characteristics of patients
Dean J. Kereiakes et al. JACC 2017;70:
Use of Targeted Temperature Management After Out-of-hospital Cardiac Arrest: A Meta- Analysis of Randomized Controlled Trials  Ahmed Mahmoud, MD, Islam.
Erratum Regarding “Preemptive Correction of Arteriovenous Access Stenosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials” (Am.
chemotherapy for patients with MC versus those with AC
Effect of PCI on 1-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval (bars);
Jennifer A. Rymer, and L. Kristin Newby BTS 2017;2:
Elliott P, et al. JAMA 2009;302:37-48.
Nat. Rev. Cardiol. doi: /nrcardio
David J.A. Jenkins et al. JACC 2018;71:
David J.A. Jenkins et al. JACC 2018;71:
The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis  Moritz C. Wyler von Ballmoos, MD, MPH, Bernhard.
John A. Bittl et al. JACC 2016;68:
Yousef Rezaei, MD  American Journal of Kidney Diseases 
Incidence of Cardiovascular Disease in Individuals with Psoriasis: A Systematic Review and Meta-Analysis  Eleanor J. Samarasekera, Julie M. Neilson, Richard.
Minimally Invasive Direct Coronary Artery Bypass Graft Surgery or Percutaneous Coronary Intervention for Proximal Left Anterior Descending Artery Stenosis:
Berger JS, et al. JAMA 2009;301:
Do the EXCEL and NOBLE Trial Results Change Meta-Analysis Findings?
Flow diagram for exclusions of trials identified RCT indicates randomized controlled trial Hulten E, et al. Arch Intern Med 2006;166:
Yin-Shu Chang, MD, Jia-Xiang Wang, MD, PhD, Da-Wei Chang, PhD 
Drug-eluting stents versus coronary artery bypass grafting for the treatment of coronary artery disease: A meta-analysis of randomized and nonrandomized.
Ahmed Abuzaid, MD, Carly Fabrizio, DO, Kevin Felpel, MD, Haitham S
Sotirios Tsimikas JACC 2017;69:
Giuseppe Gargiulo et al. JACC 2018;71:
David J.A. Jenkins et al. JACC 2018;71:
Davide Capodanno et al. JCIN 2009;2:
Associations between type of MI and incident HF
Genetic predisposition to CHD modifies the increased CHD risk associated with smoking (*) ORs adjusted for age, gender, total energy intake, alcohol intake,
Zachary L. Steinberg et al. JACC 2017;69:
Zachary L. Steinberg et al. JACC 2017;69:
MRRs and EMRRs for women with ACS
Lifetime heart failure risk*
The benefit of evolocumab treatment is consistent regardless of inflammation level HR %CI ARR 1.6% 1.8%
Christian Madelaire et al. JCHF 2018;6:
Ticagrelor versus prasugrel; risk ratio with 95% CIs for the primary composite end point, primary composite end point in those undergoing PCI, myocardial.
Effect of PCI on 3 to 5-year risk of all-cause mortality and major cardiovascular outcomes. CABG, coronary artery bypass grafting; CI, confidence interval.
Multivariate-adjusted HRs (95% CI) for deaths from CV disease (CVD), coronary heart disease (CHD), stroke, and all-cause mortality according to fasting.
Pamela E. Scott et al. JACC 2018;71:
Increase of physical activity over time associated with lower HF risk
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
Risk for cardiovascular disease and all-cause death according to RHR: (A) as categorical variable (HR≥75 bpm vs HR
Figure 7. Subgroup analysis according to the study design and support of CPB during CABG. The study design and support of CPB did not affect the results.
David J.A. Jenkins et al. JACC 2018;71:
David J.A. Jenkins et al. JACC 2018;71:
David J.A. Jenkins et al. JACC 2018;71:
Forest plot illustrating the risk ratio of myocardial infarction
Presentation transcript:

David J.A. Jenkins et al. JACC 2018;71:2570-2584 Summary Plots of Commonly Used Vitamins and Minerals Summary data showing the risk ratios derived from meta-analyses of RCTs of the 4 most commonly consumed vitamins and mineral supplements (multivitamins, vitamin D, calcium, and vitamin C) on the components of CVD and all-cause mortality. Of note, none of these popular supplements had an effect on CVD or all-cause mortality. CHD = coronary heart disease; CI = confidence interval; MI = myocardial infarction; RR = risk ratio; other abbreviations as in Figure 1. David J.A. Jenkins et al. JACC 2018;71:2570-2584 2018 The Authors